Skip to main content
Top
Published in: Sleep and Breathing 1/2024

15-08-2023 | Irritable Bowel Syndrome | Hypoxia • Letter to the Editors

The relationship between irritable bowel syndrome, the gut microbiome, and obstructive sleep apnea: the role of the gut-brain axis

Authors: Ellen M. S. Xerfan, Anamaria S. Facina, Jane Tomimori, Sergio Tufik, Monica L. Andersen

Published in: Sleep and Breathing | Issue 1/2024

Login to get access

Abstract

Sleep disruption, especially that resulting from obstructive sleep apnea (OSA) — a widely prevalent sleep disorder — can lead to important systemic repercussions. We raise a subject of current interest, namely the possible relationship between sleep in general, OSA, and irritable bowel syndrome (IBS), an intestinal disease that can be made worse by stressful events. The intermittent hypoxia caused by OSA can induce alterations in the gut microbiota, which can lead to the dysregulation of the gut-brain axis and the worsening of IBS. This may be considered to be a circular relationship, with OSA playing a crucial role in the worsening of bowel symptoms, which in turn have a negative effect on sleep. Thus, based on previous evidence, we suggest that improving sleep quality could be a key to disrupting this relationship of IBS aggravation and OSA.
Literature
1.
go back to reference Bhattarai Y, Muniz Pedrogo DA, Kashyap PC (2017) Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol 312(1):G52–G62CrossRefPubMed Bhattarai Y, Muniz Pedrogo DA, Kashyap PC (2017) Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol 312(1):G52–G62CrossRefPubMed
3.
go back to reference Lach G, Schellekens H, Dinan TG et al (2018) Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics 15:36–59CrossRefPubMed Lach G, Schellekens H, Dinan TG et al (2018) Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics 15:36–59CrossRefPubMed
5.
go back to reference Farré N, Farré R, Gozal D (2018) Sleep apnea morbidity: a consequence of microbial-immune cross-talk? Chest 154:754–759CrossRefPubMed Farré N, Farré R, Gozal D (2018) Sleep apnea morbidity: a consequence of microbial-immune cross-talk? Chest 154:754–759CrossRefPubMed
6.
go back to reference Moser G, Fournier C, Peter J (2018) Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr 168:62–66CrossRefPubMed Moser G, Fournier C, Peter J (2018) Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr 168:62–66CrossRefPubMed
7.
go back to reference Yan R, Andrew L, Marlow E et al (2021) Dietary fibre intervention for gut microbiota, sleep, and mental health in adults with irritable bowel syndrome: a scoping review. Nutrients 13(7):2159CrossRefPubMedPubMedCentral Yan R, Andrew L, Marlow E et al (2021) Dietary fibre intervention for gut microbiota, sleep, and mental health in adults with irritable bowel syndrome: a scoping review. Nutrients 13(7):2159CrossRefPubMedPubMedCentral
8.
go back to reference Zhang H, Yan Y, Shi R et al (2008) Correlation of gut hormones with irritable bowel syndrome. Digestion 78:72–76CrossRefPubMed Zhang H, Yan Y, Shi R et al (2008) Correlation of gut hormones with irritable bowel syndrome. Digestion 78:72–76CrossRefPubMed
9.
go back to reference Andersen ML, Nascimento DC, Machado RB et al (2006) Sleep disturbance induced by substance P in mice. Behav Brain Res 167:212–218CrossRefPubMed Andersen ML, Nascimento DC, Machado RB et al (2006) Sleep disturbance induced by substance P in mice. Behav Brain Res 167:212–218CrossRefPubMed
10.
go back to reference Ghiasi F, Amra B, Sebghatollahi V et al (2017) Association of irritable bowel syndrome and sleep apnea in patients referred to sleep laboratory. J Res Med Sci 22:72CrossRefPubMedPubMedCentral Ghiasi F, Amra B, Sebghatollahi V et al (2017) Association of irritable bowel syndrome and sleep apnea in patients referred to sleep laboratory. J Res Med Sci 22:72CrossRefPubMedPubMedCentral
11.
go back to reference Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A (2003) Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep 26(6):747–752CrossRefPubMed Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A (2003) Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep 26(6):747–752CrossRefPubMed
12.
go back to reference Settanni CR, Ianiro G, Ponziani FR et al (2021) COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanisms. World J Gastroenterol 27(43):7433–7445CrossRefPubMedPubMedCentral Settanni CR, Ianiro G, Ponziani FR et al (2021) COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanisms. World J Gastroenterol 27(43):7433–7445CrossRefPubMedPubMedCentral
Metadata
Title
The relationship between irritable bowel syndrome, the gut microbiome, and obstructive sleep apnea: the role of the gut-brain axis
Authors
Ellen M. S. Xerfan
Anamaria S. Facina
Jane Tomimori
Sergio Tufik
Monica L. Andersen
Publication date
15-08-2023
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 1/2024
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-023-02898-x

Other articles of this Issue 1/2024

Sleep and Breathing 1/2024 Go to the issue

Sleep Breathing Physiology and Disorders • Review

Influence of nutrition and food on sleep—is there evidence?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine